1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Navigating the Future of Coronary Interventional Devices
The coronary interventional devices sector stands at the forefront of cardiovascular innovation, driven by an aging population, rising prevalence of coronary artery disease, and continuous technological breakthroughs. Invasive and minimally invasive interventions have transformed patient outcomes, reducing complication rates and enhancing long-term vessel patency. As healthcare systems strive to optimize procedural efficiency and cost-effectiveness, the demand for advanced stents, balloon catheters, and atherectomy solutions continues to surge.This executive summary offers a distilled overview of the key market dynamics, regulatory catalysts, and competitive forces shaping the landscape. Drawing on rigorous research and expert validation, it provides decision-makers with actionable insights to navigate evolving clinical practices, supply chain complexities, and emerging regional opportunities. By integrating historical perspectives with current strategic imperatives, this analysis equips stakeholders with the knowledge to anticipate shifts and seize growth avenues in the dynamic world of coronary interventional devices.
Pivotal Disruptions Shaping the Coronary Device Landscape
The coronary interventional devices marketplace has undergone seismic shifts in recent years, fueled by breakthroughs in material science and digital integration. Drug-eluting stents constructed from cobalt chromium and platinum chromium alloys are redefining vessel compatibility and minimizing restenosis, while bioresorbable vascular scaffolds are approaching clinical viability by offering temporary mechanical support without long-term implant burden. Simultaneously, balloon catheter technology has evolved beyond mere dilation to incorporate precision scoring and localized drug delivery, enhancing lesion preparation and therapeutic efficacy.On the procedural front, atherectomy systems have expanded beyond rotational models to include orbital and laser platforms that address complex plaque morphologies with greater safety margins. These technological advances are underpinned by real-time imaging and intravascular diagnostic tools that guide device selection and deployment with unprecedented accuracy. As payer pressures intensify, manufacturers are also embedding cost-containment features and value-based propositions into their portfolios, signaling a shift toward outcome-driven device adoption.
Understanding the 2025 US Tariff Implications on Device Supply
The introduction of revised tariffs on coronary interventional imports in 2025 has rippled across supply chains, elevating raw material costs and prompting strategic reshoring initiatives. Manufacturers reliant on stainless steel and specialized alloys for drug-eluting stent platforms have encountered margin pressures, compelling them to negotiate with domestic suppliers or explore alternative material formulations. Balloon catheter production lines face similar challenges as precision polymer components and drug coatings absorb added duties, forcing upward pricing adjustments that may strain hospital budgets and reimbursement frameworks.In response, several key players have accelerated investments in local manufacturing hubs to mitigate tariff exposure and ensure continuity of supply. This has spurred collaboration between device companies and contract manufacturing organizations within North America, fostering a more resilient ecosystem. However, smaller innovators and emerging entrants may struggle to absorb these incremental costs, potentially slowing the pace of novel product introductions. Ultimately, the 2025 tariff environment underscores the importance of flexible sourcing strategies and strategic alliances to preserve competitive positioning.
Dissecting Market Segmentation to Uncover Growth Drivers
A granular view of the market reveals distinct behavior across multiple product classes. In stent technologies, drug-eluting variants dominate adoption curves, propelled by the superior clinical outcomes of cobalt chromium and platinum chromium platforms, while stainless steel alternatives retain a presence in cost-sensitive segments. Bioresorbable scaffolds, having cleared initial regulatory hurdles, are poised for selective adoption among centers prioritizing long-term vessel healing.Balloon catheter offerings demonstrate a maturation in therapeutic sophistication. Conventional models maintain high volume in routine angioplasty, but drug-coated devices are rapidly gaining traction where restenosis risk is elevated. Cutting and scoring catheters command specialization roles, particularly in complex interventions that demand precise plaque modification.
Within the atherectomy domain, rotational systems continue to lead on established use cases, yet orbital techniques are carving a niche in lesion preparation for heavily calcified arteries, and laser technologies are expanding indications in chronic total occlusions. Each modality commands a defined user base across ambulatory surgical centers seeking minimally invasive workflows, large hospital networks prioritizing throughput and advanced specialty clinics focusing on high-complexity cases.
Distribution channels reflect an omnichannel paradigm. Direct partnerships between manufacturers and flagship institutions coexist with established distributor networks that ensure broad geographic coverage. Online procurement platforms are emerging as a complementary route for smaller clinics, offering transparency on pricing and expedited fulfillment.
Regional Performance Patterns in the Coronary Devices Arena
Regional dynamics exhibit divergent trajectories shaped by demographic trends, healthcare infrastructure, and reimbursement frameworks. In the Americas, robust procedural volume and well-established private hospital networks support early adoption of next-generation stents and complex catheter systems. Conversely, pricing pressures and regulatory scrutiny place a premium on cost-effective solutions, encouraging bundled procurement agreements.Across the Europe, Middle East & Africa corridor, heterogeneous reimbursement landscapes and varying clinical guidelines influence device mix. Western European markets prioritize incremental innovations that demonstrate clear outcome advantages, while emerging economies within the region weigh capital expenditure against broader access objectives. In the Gulf states, strategic investments in medical tourism and state-of-the-art cath lab facilities are accelerating uptake of premium interventional technologies.
The Asia-Pacific region is defined by dual forces of rapid urbanization and governmental healthcare reforms aimed at expanding coverage. High-volume markets such as China and India present vast growth potential, but require strategic localization of manufacturing and pricing strategies to address diverse payer systems. Meanwhile, mature markets like Japan and Australia continue to lead in clinical trial participation and adoption of cutting-edge scaffolding and atherectomy platforms, reinforcing their positions as innovation hubs.
Competitive Dynamics Highlighting Leading Industry Players
The competitive environment features a blend of global incumbents and agile challengers. Medtronic extends its leadership through integrated therapy platforms spanning stents, guidewires, and imaging catheters, leveraging its strong service network to drive cross-sell opportunities. Abbott Laboratories capitalizes on its drug-eluting stent legacy by refining alloy compositions and expanding its portfolio to encompass next-generation scaffold technologies.Boston Scientific pursues a differentiated approach with its drug-coated balloon and specialized atherectomy offerings, targeting niche clinical segments where restenosis and calcification pose significant challenges. Terumo Corporation prioritizes interventional versatility through its modular catheter systems and digital procedure navigation tools, aiming to enhance operator precision. Emerging players such as B. Braun Melsungen focus on market entry by forging distributor partnerships and investing in localized manufacturing to offer competitive pricing bands in growth markets.
Strategic alliances, licensing agreements, and selective acquisitions continue to reshape the field, as companies seek to complement their core competencies in drug delivery, device design, and procedural support services. This dynamic is fostering an environment where collaboration often supersedes direct confrontation, accelerating product innovation while managing development risk.
Strategic Imperatives to Capitalize on Emerging Opportunities
Industry leaders must realign their innovation pipelines to capture the evolving clinical and economic imperatives. Prioritizing development of next-generation bioresorbable scaffolds with proven long-term safety profiles will address growing clinician demand for temporary implants. Simultaneously, expanding indications for drug-coated balloons in peripheral applications can diversify revenue streams and leverage existing R&D investments.Supply chain resilience demands diversification of sourcing and enhanced visibility into raw material flows. Establishing dual-sourcing arrangements for critical alloys and polymer components will mitigate tariff volatility and logistical disruptions. Digitalization of inventory management across direct, distributor, and online channels can further optimize procurement, ensuring real-time demand forecasting and cost containment.
Deepening engagement with payers and health technology assessment bodies will be critical to securing favorable reimbursement terms. Generating robust real-world evidence and health economic data that demonstrate value-based outcomes can unlock access in price-sensitive regions. Finally, cultivating strategic partnerships with leading health systems and specialized clinics will expedite clinical trials and foster early adoption of innovative devices, solidifying market leadership.
Rigorous Methodological Framework Underpinning Our Research
This research employs a mixed-methods approach, integrating primary interviews with interventional cardiologists, procurement executives, and industry experts alongside comprehensive secondary data analysis from regulatory filings, clinical registries, and trade databases. Segmentation insights are validated through cross-referencing manufacturer disclosures with hospital procedure volumes and device utilization trends.Regional performance patterns are assessed via desk research on healthcare expenditure, demographic projections, and policy environments, while tariff implications are modeled using import data and duty schedules. Competitive landscapes draw on financial reports, patent analyses, and partnership announcements to map strategic trajectories. Throughout, data triangulation ensures the robustness of conclusions, with iterative feedback loops between analysts and domain experts to refine interpretations and identify emerging inflection points.
Synthesizing Insights for Informed Decision Making
By synthesizing insights across technological advancements, policy shifts, and regional dynamics, this summary provides a cohesive vantage on where value creation is most pronounced. Stakeholders seeking to optimize portfolios, refine go-to-market models, or establish new manufacturing footprints will find the distilled analysis invaluable.The interplay between segmentation nuances, tariff pressures, and competitive positioning underscores the necessity of a multifaceted strategy. Whether focusing on high-performance stent alloys or tailored catheter solutions, organizations that align R&D, supply chain, and commercial execution will emerge as frontrunners in the evolving coronary interventional ecosystem.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:- Stent Type
- Bare Metal Stent
- Bioresorbable Vascular Scaffold
- Drug Eluting Stent
- Cobalt Chromium
- Platinum Chromium
- Stainless Steel
- Balloon Catheter
- Conventional Balloon Catheter
- Cutting Balloon Catheter
- Drug Coated Balloon Catheter
- Scoring Balloon Catheter
- Atherectomy System
- Laser Atherectomy System
- Orbital Atherectomy System
- Rotational Atherectomy System
- User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
- Distribution Channel
- Direct
- Distributor
- Online
- Americas
- United States
- California
- Texas
- New York
- Florida
- Illinois
- Pennsylvania
- Ohio
- Canada
- Mexico
- Brazil
- Argentina
- United States
- Europe, Middle East & Africa
- United Kingdom
- Germany
- France
- Russia
- Italy
- Spain
- United Arab Emirates
- Saudi Arabia
- South Africa
- Denmark
- Netherlands
- Qatar
- Finland
- Sweden
- Nigeria
- Egypt
- Turkey
- Israel
- Norway
- Poland
- Switzerland
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Malaysia
- Singapore
- Vietnam
- Taiwan
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Biotronik SE & Co. KG
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- Cook Medical LLC
- Teleflex Incorporated
- MicroPort Scientific Corporation
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Interventional Devices Market, by Stent Type
8.1. Introduction
8.2. Bare Metal Stent
8.3. Bioresorbable Vascular Scaffold
8.4. Drug Eluting Stent
8.4.1. Cobalt Chromium
8.4.2. Platinum Chromium
8.4.3. Stainless Steel
9. Coronary Interventional Devices Market, by Balloon Catheter
9.1. Introduction
9.2. Conventional Balloon Catheter
9.3. Cutting Balloon Catheter
9.4. Drug Coated Balloon Catheter
9.5. Scoring Balloon Catheter
10. Coronary Interventional Devices Market, by Atherectomy System
10.1. Introduction
10.2. Laser Atherectomy System
10.3. Orbital Atherectomy System
10.4. Rotational Atherectomy System
11. Coronary Interventional Devices Market, by User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Coronary Interventional Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct
12.3. Distributor
12.4. Online
13. Americas Coronary Interventional Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Coronary Interventional Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Coronary Interventional Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Boston Scientific Corporation
16.3.3. Medtronic plc
16.3.4. Terumo Corporation
16.3.5. Biotronik SE & Co. KG
16.3.6. Cardinal Health, Inc.
16.3.7. B. Braun Melsungen AG
16.3.8. Cook Medical LLC
16.3.9. Teleflex Incorporated
16.3.10. MicroPort Scientific Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CORONARY INTERVENTIONAL DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CORONARY INTERVENTIONAL DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY INTERVENTIONAL DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CORONARY INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CORONARY INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONARY INTERVENTIONAL DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CONVENTIONAL BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CUTTING BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY SCORING BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 47. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 48. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 49. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 50. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 84. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 85. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 86. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 87. GERMANY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 102. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 103. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 104. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 105. ITALY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 108. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 109. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 110. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 111. SPAIN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 144. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 145. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 146. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 150. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 151. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 152. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 153. FINLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 169. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 170. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 171. EGYPT CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 174. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 176. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 177. TURKEY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 186. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 187. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 188. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 189. NORWAY CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 192. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 193. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 194. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 195. POLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 209. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 211. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 212. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 213. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 214. CHINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 217. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 218. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 219. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 220. INDIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 223. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 224. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 225. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 226. JAPAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 247. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 248. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 249. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 250. THAILAND CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING STENT, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEM, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. CORONARY INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 282. CORONARY INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
Companies Mentioned
The companies profiled in this Coronary Interventional Devices market report include:- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Biotronik SE & Co. KG
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- Cook Medical LLC
- Teleflex Incorporated
- MicroPort Scientific Corporation
Methodology
LOADING...
